Indoco Remedies Intrinsic Value
INDOCO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹569.03 | ₹512.13 - ₹625.93 | +150.0% | Book Value/Share: ₹565.56, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹455.22 | ₹409.70 - ₹500.74 | +100.0% | Revenue/Share: ₹1051.11, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹455.22 | ₹409.70 - ₹500.74 | +100.0% | EBITDA: ₹120.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹466.53 | ₹373.22 - ₹559.84 | +105.0% | CF Growth: 3.7%, Discount: 15% |
Want to compare with current market value? Check INDOCO share price latest .
Valuation Comparison Chart
INDOCO Intrinsic Value Analysis
What is the intrinsic value of INDOCO?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Indoco Remedies (INDOCO) is ₹466.53 (median value). With the current market price of ₹227.61, this represents a +105.0% variance from our estimated fair value.
The valuation range spans from ₹455.22 to ₹569.03, indicating ₹455.22 - ₹569.03.
Is INDOCO undervalued or overvalued?
Based on our multi-method analysis, Indoco Remedies (INDOCO) appears to be trading below calculated value by approximately 105.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.66 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.39 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | -3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Indoco Remedies
Additional stock information and data for INDOCO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹95 Cr | ₹-75 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹155 Cr | ₹-61 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹179 Cr | ₹75 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹174 Cr | ₹114 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹82 Cr | ₹49 Cr | Positive Free Cash Flow | 8/10 |